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Systemic sclerosis (SSc, scleroderma) is characterized by early perivascular inflam-
mation, microvascular endothelial cell (MVEC) activation/damage and defective 
angiogenesis. Junctional adhesion molecules (JAMs) regulate leukocyte recruitment 
to sites of inflammation and ischemia-reperfusion injury, vascular permeability and 
angiogenesis. In the present study, we investigated the possible role of JAMs in SSc 
pathogenesis.The expression of JAM-A and JAM-C in skin biopsies from 25 patients 
with SSc (14 early-stage SSc, 11 late-stage SSc) and 15 healthy subjects was investi-
gated by immunohistochemistry and western blotting. Subcellular localization of 
JAMs in cultured dermal healthy MVECs (H-MVECs) and early-stage SSc-MVECs 
was assessed by confocal laser scanning microscopy. Serum levels of soluble JAM-A 
(sJAM-A) and JAM-C (sJAM-C) from 64 SSc patients (25 early-stage SSc, 39 late-stage 
SSc) and 32 healthy subjects were examined by ELISA.In control skin, constitutive 
JAM-A expression was observed in dermal MVECs and fibroblasts. In early-stage SSc 
skin, JAM-A expression was strongly increased in MVECs, fibroblasts and perivascu-
lar infiltrating inflammatory cells. In late-stage SSc, JAM-A expression was decreased 
compared with healthy controls. JAM-C was weakly expressed in control and late-
stage SSc skin, while it was strongly expressed in MVECs, fibroblasts and inflamma-
tory cells from early-stage SSc skin. Cell surface expression of JAM-A was higher in 
early-stage SSc-MVECs and increased in H-MVECs upon stimulation with early-stage 
SSc sera. JAM-C was cytoplasmic in resting H-MVECs, while it was rapidly recruited 
to the cell surface upon challenging with early-stage SSc sera. Early-stage SSc-MVECs 
exhibited increased expression and constitutive localization of JAM-C on the cell sur-
face. Circulating levels of sJAM-A and sJAM-C were significantly increased in early-
stage SSc compared with healthy controls and late-stage SSc. In addition, sJAM-A 
and sJAM-C levels were significantly raised in SSc patients with ‘early/active’ nail-
fold capillaroscopic pattern compared with those with ‘late’ capillaroscopic pattern.
Collectively, the results of our study suggest that JAMs may participate in der-
mal MVEC activation, inflammatory processes and impaired angiogenesis in different 
stages of SSc.
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